| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.939 | 0.004 | 0.939 | Cyclophilin D inhibitor | 0.886 0.005 CID_18936387 | ||
| 0.78 | 0.018 | 0.78 | Antiinflammatory | 0.68 0.035 CID_18936387 | ||
| 0.76 | 0.004 | 0.76 | Lipoxygenase inhibitor | 0.699 0.005 CID_18936387 | ||
| 0.735 | 0.005 | 0.735 | Free radical scavenger | 0.547 0.012 CID_18936387 | ||
| 0.713 | 0.005 | 0.713 | Hypoglycemic | 0.592 0.009 CID_18936387 | ||
| 0.669 | 0.003 | 0.669 | Lipid peroxidase inhibitor | 0.547 0.004 CID_18936387 | ||
| 0.608 | 0.006 | 0.608 | Hypolipemic | 0.549 0.009 CID_18936387 | ||
| 0.497 | 0.02 | 0.497 | Antioxidant | 0.434 0.029 CID_18936387 | ||
| 0.475 | 0.037 | 0.475 | Cholesterol antagonist | 0.446 0.041 CID_18936387 | ||
| 0.435 | 0.009 | 0.435 | Sodium/bile acid cotransporter inhibitor | 0.403 0.016 CID_18936387 | ||
| 0.326 | 0.001 | 0.326 | Thiazolidinedione | 0.226 0.001 CID_18936387 | ||
| 0.345 | 0.023 | 0.36 | ErbB-1 antagonist | 0.36 0.021 CID_18936387 | CID_18936387 | |
| 0.318 | 0.004 | 0.318 | Peroxisome proliferator-activated receptor gamma agonist | 0.168 0.009 CID_18936387 | ||
| 0.323 | 0.014 | 0.336 | Cyclooxygenase inhibitor | 0.336 0.013 CID_18936387 | CID_18936387 | |
| 0.308 | 0.004 | 0.308 | Aldose reductase inhibitor | 0.228 0.006 CID_18936387 | ||
| 0.344 | 0.048 | 0.347 | Interleukin 2 agonist | 0.347 0.047 CID_18936387 | CID_18936387 | |
| 0.301 | 0.005 | 0.301 | ABCA1 expression enhancer | 0.245 0.006 CID_18936387 | ||
| 0.304 | 0.01 | 0.335 | 5-Lipoxygenase inhibitor | 0.335 0.008 CID_18936387 | CID_18936387 | |
| 0.362 | 0.08 | 0.362 | Immunosuppressant | 0.312 0.108 CID_18936387 | ||
| 0.292 | 0.019 | 0.292 | NOS3 expression enhancer | 0.195 0.043 CID_18936387 | ||
| 0.279 | 0.036 | 0.279 | Hepatoprotectant | 0.156 0.103 CID_18936387 | ||
| 0.259 | 0.021 | 0.316 | Interleukin 6 antagonist | 0.316 0.013 CID_18936387 | CID_18936387 | |
| 0.256 | 0.031 | 0.256 | Insulin sensitizer | 0.212 0.061 CID_18936387 | ||
| 0.241 | 0.027 | 0.241 | Bone formation stimulant | 0.24 0.027 CID_18936387 | ||
| 0.201 | 0.013 | 0.201 | Mucolytic | 0.181 0.019 CID_18936387 | ||
| 0.199 | 0.02 | 0.199 | Expectorant | 0.169 0.028 CID_18936387 | ||
| 0.192 | 0.017 | 0.192 | Adenylate cyclase stimulant | 0.191 0.018 CID_18936387 | ||
| 0.165 | 0.005 | 0.165 | Maillard reaction inhibitor | 0.143 0.006 CID_18936387 | ||
| 0.181 | 0.037 | 0.181 | Neurotrophic factor | 0.18 0.038 CID_18936387 | ||
| 0.185 | 0.041 | 0.213 | Cyclooxygenase 1 inhibitor | 0.213 0.029 CID_18936387 | CID_18936387 | |
| 0.245 | 0.105 | 0.245 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.177 | 0.069 | 0.177 | Growth hormone agonist | 0.174 0.071 CID_18936387 | ||
| 0.106 | 0.004 | 0.106 | Adenine nucleotide translocase inhibitor | 0.106 0.004 CID_18936387 | ||
| 0.163 | 0.062 | 0.163 | Insulin secretagoues | 0.127 0.101 CID_18936387 | ||
| 0.168 | 0.068 | 0.168 | Arachidonic acid antagonist | 0.161 0.075 CID_18936387 | ||
| 0.155 | 0.069 | 0.155 | Phospholipase A2 inhibitor | 0.142 0.084 CID_18936387 | ||
| 0.068 | 0.003 | 0.068 | Thyroid hormone agonist | 0.062 0.004 CID_18936387 | ||
| 0.218 | 0.156 | 0.267 | Antithrombotic | 0.267 0.113 CID_18936387 | CID_18936387 | |
| 0.257 | 0.197 | 0.257 | Calcium channel L-type activator | 0.257 0.197 CID_18936387 | ||
| 0.064 | 0.004 | 0.064 | Free fatty acid receptor 1 agonist | 0.023 0.008 CID_18936387 | ||
| 0.089 | 0.032 | 0.126 | Leukotriene synthesis inhibitor | 0.126 0.015 CID_18936387 | CID_18936387 | |
| 0.082 | 0.031 | 0.082 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.058 CID_18936387 | ||
| 0.083 | 0.034 | 0.088 | Glycine receptor agonist | 0.088 0.03 CID_18936387 | CID_18936387 | |
| 0.167 | 0.126 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 CID_18936387 | CID_18936387 | |
| 0.159 | 0.124 | 0.159 | Neurotrophic factor enhancer | 0.152 0.135 CID_18936387 | ||
| 0.232 | 0.2 | 0.232 | Analgesic | |||
| 0.076 | 0.044 | 0.076 | Calcium channel L-type blocker | 0.075 0.045 CID_18936387 | ||
| 0.17 | 0.148 | 0.188 | Calpain inhibitor | 0.188 0.125 CID_18936387 | CID_18936387 | |
| 0.073 | 0.051 | 0.073 | Lipase inhibitor | |||
| 0.081 | 0.062 | 0.081 | Estrogen-related receptor beta agonist | 0.08 0.068 CID_18936387 | ||
| 0.122 | 0.106 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.085 CID_18936387 | CID_18936387 | |
| 0.03 | 0.014 | 0.03 | Motilin receptor antagonist | 0.03 0.015 CID_18936387 | ||
| 0.093 | 0.079 | 0.093 | Ferrochelatase inhibitor | 0.093 0.079 CID_18936387 | ||
| 0.015 | 0.004 | 0.015 | Thyroid hormone beta agonist | 0.013 0.004 CID_18936387 | ||
| 0.018 | 0.014 | 0.018 | Retinoic acid receptor antagonist | 0.018 0.014 CID_18936387 | ||
| 0.03 | 0.026 | 0.03 | Estrogen-related receptor alpha antagonist | |||
| 0.154 | 0.151 | 0.154 | Immunostimulant | |||
| 0.031 | 0.028 | 0.031 | Retinoid X receptor agonist | |||
| 0.039 | 0.037 | 0.039 | HIV-1 protease inhibitor | |||
| 0.037 | 0.039 | 0.038 | VCAM-1 antagonist | 0.038 0.034 CID_18936387 | CID_18936387 | |
| 0.036 | 0.04 | 0.038 | VCAM antagonist | 0.038 0.034 CID_18936387 | CID_18936387 | |
| 0.185 | 0.226 | 0.215 | Antiobesity | 0.215 0.192 CID_18936387 | CID_18936387 | |
| 0.102 | 0.15 | 0.12 | Farnesoid X receptor antagonist | 0.12 0.105 CID_18936387 | CID_18936387 | |
| 0.004 | 0.121 | 0.031 | Estrogen receptor alpha agonist | 0.031 0.025 CID_18936387 | CID_18936387 | |
| 0.096 | 0.216 | 0.156 | Aldehyde oxidase inhibitor | 0.156 0.134 CID_18936387 | CID_18936387 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |